These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 6461066
1. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism]. Hoffmeyer P, Groebli Y, Spiliopoulos A, Jung A. Schweiz Med Wochenschr; 1982 Jan 23; 112(4):118-20. PubMed ID: 6461066 [Abstract] [Full Text] [Related]
2. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism. Jansson S, Tisell LE, Lindstedt G, Lundberg PA. Surgery; 1991 Sep 23; 110(3):480-6. PubMed ID: 1845370 [Abstract] [Full Text] [Related]
6. [Preoperative normalization of hypercalcemia, caused by parathyroid cancer, by intravenous administration of dichloromethylene diphosphonate]. Conte N, Di Virgilio R, Roiter I. Minerva Endocrinol; 1984 Sep 23; 9(1):47-8. PubMed ID: 6239086 [No Abstract] [Full Text] [Related]
7. Mineralization defect but no effect on hypercalcemia during clodronate treatment in secondary hyperparathyroidism. Ring T, Sodemann B, Nielsen C, Melsen F, Kornerup HJ. Clin Nephrol; 1995 Sep 23; 44(3):209-10. PubMed ID: 8556838 [Abstract] [Full Text] [Related]
8. Posttraumatic parathyroid crisis and severe hypercalcemia treated with intravenous bisphosphonate (APD). Case report. Canivet JL, Damas P, Lamy M. Acta Anaesthesiol Belg; 1990 Sep 23; 41(1):47-50. PubMed ID: 2360392 [Abstract] [Full Text] [Related]
9. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease. Douglas DL, Duckworth T, Russell RG, Kanis JA, Preston CJ, Preston FE, Prenton MA, Woodhead JS. Lancet; 1980 May 17; 1(8177):1043-7. PubMed ID: 6103389 [Abstract] [Full Text] [Related]
11. [Suppression of severe hypocalcemia associated with malignant lymphoma by intravenous administration of dichloromethylene diphosphonate]. Tschopp JM, Jung A, Miescher PA. Schweiz Med Wochenschr; 1981 Oct 31; 111(44):1655-7. PubMed ID: 6458087 [Abstract] [Full Text] [Related]
13. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases. Chapuy MC, Meunier PJ, Alexandre CM, Vignon EP. J Clin Invest; 1980 May 31; 65(5):1243-7. PubMed ID: 6444955 [Abstract] [Full Text] [Related]
14. Treatment with clodronate in patients with hypercalcemia secondary to malignancy. Lind L, Wengle B, Ljunghall S. Ups J Med Sci; 1987 May 31; 92(3):259-63. PubMed ID: 2966487 [Abstract] [Full Text] [Related]
15. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate. Shane E, Jacobs TP, Siris ES, Steinberg SF, Stoddart K, Canfield RE, Bilezikian JP. Am J Med; 1982 Jun 31; 72(6):939-44. PubMed ID: 6211978 [Abstract] [Full Text] [Related]
17. [Neoplastic hypercalcemia with renal insufficiency: treatment with dichloromethylene diphosphonate]. Conte N, Di Virgilio R, Roiter I, Foscolo G, Baruffi C. Clin Ter; 1985 Nov 15; 115(3):177-80. PubMed ID: 2935356 [No Abstract] [Full Text] [Related]
18. Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma. Vega EM, Mautalen CA. Medicina (B Aires); 1991 Nov 15; 51(2):106-10. PubMed ID: 1820495 [Abstract] [Full Text] [Related]